Dinaciclib is a potent and selective inhibitor of cyclin-dependent kinases CDK1, CDK2, CDK5, and CDK9 (IC50s respectively: 3 nM, 1 nM, 1 nM, and 4 nM).1,2 Active across multiple human cancer cell lines and in mouse xenograft models.3-9
* VAT and and shipping costs not included. Errors and price changes excepted
